U.S. Markets closed

Takeda Dives After Guiding To Losses Following Shire Megamerger

ALLISON GATLIN
Takeda Dives After Guiding To Losses Following Shire Megamerger

Takeda Pharmaceutical stock plunged Tuesday after the pharmaceutical company said it expects nearly $2 billion in operating losses this year related to its megamerger with Shire.